ARIAD is a global biotechnology company focused exclusively, passionately, on cancer.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines.
Our vision, mission and values
Clarity and purpose for our journey together.More
Watch and learn about what we do and what we believe.View
The right mix of talent, expertise and experience.More
See some of our people working together to discover, develop and deliver.View